Retractable Technologies Reports $4.2 Million Net Loss in Q1 2026, Revenue Declines 13.5%

Retractable Technologies, Inc. reported a net loss of $4.2 million for the first quarter of 2026, a significant improvement compared to a net loss of $10.5 million in the same period of 2025. The company's revenue for the quarter was $7.2 million, down 13.5% from $8.3 million year-over-year. This decline in sales was attributed to a decrease in average selling prices and a shift in product mix, despite a 3.6% increase in overall unit sales. The company’s gross profit margin remained negative, reflecting ongoing challenges in cost management, particularly due to tariffs and increased operational expenses.

In terms of operational metrics, domestic sales accounted for 82.9% of total revenues, down from 89.6% in the previous year, while international sales surged by 42.4%, primarily driven by increased demand for EasyPoint® needle products. The company reported that it sourced 61% of its products from manufacturers in China, which are subject to high tariffs, impacting overall costs. The company has been actively working to mitigate these costs through strategic sourcing and increased domestic production capabilities.

The company’s total assets decreased to $137.6 million as of March 31, 2026, down from $142.6 million at the end of 2025. Current assets also fell, primarily due to a decrease in accounts receivable and inventories. The company’s cash and cash equivalents increased to $2.8 million, reflecting a net cash inflow from investing activities, which included the liquidation of investments to support operational needs. However, cash used in operating activities remained a concern, with $1.4 million utilized during the quarter.

Strategically, Retractable Technologies has made significant changes, including a 16% reduction in workforce aimed at saving approximately $2.2 million annually. This decision was made in response to rising operational costs and is expected to streamline operations. The company also continues to adapt its manufacturing capabilities to increase domestic production of certain products, which is anticipated to reduce reliance on imports and mitigate tariff impacts in the long term.

Looking ahead, the company remains cautious about the ongoing effects of tariffs and market conditions. The management anticipates that international sales will continue to grow, particularly following recent certifications under European Union regulations. However, the uncertainty surrounding future tariff rates and their potential impact on sourcing and pricing strategies remains a critical concern for the company’s financial outlook.